Antibody response six months after the booster dose of Pfizer in
previous recipients of CoronaVac
AbstractWe evaluated antibody levels after six months of the booster dose with
BNT162B2 in previous recipients of CoronaVac and whether a subsequent
SARS-COV-2 infection enhances the antibody response. The booster shot
induced IgM and IgG antibodies against Spike protein. Infection after
vaccination increased antibodies against protein N.